| Application no. and date | 06809207.1 (espacenet) (Federated) (European Patent Register), 20061102 | | Patent/reg. no. and date | DK/EP 1957106, 20131016 | | Publication date | 20080820 | | Priority no. and date | US 736623 P, 20051114 | | EP pub. no. and date |
EP 1957106 20080820 | | Effective date | | | Applicant/owner | Teva Pharmaceuticals International GmbH, Schlüsselstrasse 12
8645 Jona, CH | | Applicant ref. no. | P63700DK01 | | Inventor | ZELLER, Joerg, Rinat Neuroscience Corp.
230 East Grand Avenue
South San Francisco, California 94080, US,
PONS, Jaume, Rinat Neuroscience Corp.
230 East Grand Avenue
South San Francisco, California 94080, US,
ROSENTHAL, Arnon, 150 Normandy Lane
Woodside, California 94062, US,
POULSEN, Kristian Todd, Rinat Neuroscience Corp.
230 East Grand Avenue
South San Francisco, California 94080, US,
ABDICHE, Yasmina Noubia, Rinat Neuroscience Corp.
230 East Grand Avenue
South San Francisco, California 94080, US,
COLLIER, Sierra Jones, Rinat Neuroscience Corp.
230 East Grand Avenue
South San Francisco, California 94080, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61P 25/00 (2006.01) , C07K 16/26 (2006.01) | | Title | ANTAGONIST-ANTISTOFFER, DER ER RETTET MOD CALCITONIN-GEN-RELATERET PEPTID OG FREMGANGSMÅDER TIL ANVENDELSE AF DISSE | | Int. application no. | IB2006003181 | | Int. publication no. | WO2007054809 | | Related patent (certificate) | CA 2019 00026 | | Status | Ændret DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
